PMAS

PMAS

To support clients in making early value assumptions Valid Insight developed PMAS to assess willingness-to-pay and incremental product value

  • PMAS uses proprietary algorithms based on multi-criteria decision analysis of over 10 years of reimbursement and pricing decisions in multiple markets.
  • PMAS allows our clients to evaluate their product’s pricing and funding potential rapidly and effectively, based on anticipated evidence.
  • PMAS can predict pricing and reimbursement outcome at any stage before a product is launched, however, it is most useful for predictions pre-phase III.
  • PMAS highlights where to focus future development of the compound in order to support optimal pricing and access for a new product

PMAS key output screenshots

PMAS (Pricing and Market Access Simulator)

PMAS provides a visual display of the possibility for premium, breakthrough, discount or comparative pricing and highlights key drivers and limitations of these pricing results to support clinical development.